These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16554455)
21. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. Schmidt BM; Timmer W; Georgens AC; Hilt M; Mattinger C; Wurst W; Hörmann K; Wehling M J Clin Pharmacol; 1999 Oct; 39(10):1062-9. PubMed ID: 10516941 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar. Nave R; Gunawardena KA; Zech K; Bethke TD Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964 [TBL] [Abstract][Full Text] [Related]
23. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis. Nayak AS; Ellis MH; Gross GN; Mendelson LM; Schenkel EJ; Lanier BQ; Simpson B; Mullin ME; Smith JA J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):157-62. PubMed ID: 9500747 [TBL] [Abstract][Full Text] [Related]
24. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Dorow P; Aurich R; Petzold U Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785 [TBL] [Abstract][Full Text] [Related]
26. In brief: two intranasal corticosteroid HFA aerosols for allergic rhinitis. Med Lett Drugs Ther; 2012 Oct; 54(1401):84. PubMed ID: 23120798 [No Abstract] [Full Text] [Related]
27. Ciclesonide for the treatment of seasonal allergic rhinitis. Jacobs RL Expert Rev Clin Immunol; 2011 Nov; 7(6):735-41. PubMed ID: 22014013 [TBL] [Abstract][Full Text] [Related]
28. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis. Gradman J; Caldwell MF; Wolthers OD Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555 [TBL] [Abstract][Full Text] [Related]
29. An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide in Human Serum and Its Application to a Clinical Study. Chen YL; Wang W; Gatien Ngounou Wetie A; Shi L; Eddy J; John Lin ZP; Sunkaraneni S J Appl Lab Med; 2020 Jan; 5(1):41-53. PubMed ID: 31662413 [TBL] [Abstract][Full Text] [Related]
30. Budesonide - a new steroid for intranasal use. A double-blind clinical comparison between budesonide and placebo in patients with seasonal allergic rhinitis. Warland A; Møller P; Lindqvist N Allergy; 1981 Aug; 36(6):425-8. PubMed ID: 7032343 [TBL] [Abstract][Full Text] [Related]
31. Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model. Rohatagi S; Krishnaswami S; Pfister M; Sahasranaman S Am J Ther; 2005; 12(5):385-97. PubMed ID: 16148423 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Karaki M; Akiyama K; Mori N Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of ciclesonide and its active metabolite desisobutyryl-ciclesonide in human plasma by LC-APCI-MS/MS: application to pharmacokinetic study in healthy Chinese volunteers. Su MX; Song M; Zhuang Y; Wang YQ; Hang TJ J Pharm Biomed Anal; 2011 Apr; 55(1):230-5. PubMed ID: 21296519 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis. Badorrek P; Hohlfeld JM; Krug N; Joshi A; Raut A Ann Allergy Asthma Immunol; 2015 Oct; 115(4):325-329.e1. PubMed ID: 26272281 [TBL] [Abstract][Full Text] [Related]
35. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. Pearlman DS; Berger WE; Kerwin E; Laforce C; Kundu S; Banerji D J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447 [TBL] [Abstract][Full Text] [Related]
36. First-in-human study on pharmacokinetics, safety, and tolerability of single and multiple escalating doses of PA9159 nasal spray, a highly potent glucocorticoid in healthy Chinese volunteers. Guo S; Hu Y; Wang C; Zhang Y; Wu F; Ni S; Dai Y; Han Y; Hu M; Lu C; Xi Z; Lu L; Zhao X; Zhang L Eur J Pharm Sci; 2024 Sep; 200():106764. PubMed ID: 38599506 [TBL] [Abstract][Full Text] [Related]
37. Intranasal corticosteroids in the treatment of allergic rhinitis. Ratner PH; Stoloff S; Meltzer EO; Hadley JA Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841 [TBL] [Abstract][Full Text] [Related]
38. Ciclesonide. BY 9010, ciclesonide-DPI, ciclesonide-MDI, EL 876. Drugs R D; 2002; 3(6):407-10. PubMed ID: 12516947 [No Abstract] [Full Text] [Related]
39. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]